Galactose for Interference Testing

• Description:

  Galactose for Interference Testing_x000D_ Catalog number: C2010416_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 500 mg_x000D_ Molecular Weight or Concentration: 180.16 g/mol_x000D_ Supplied as: Powder_x000D_ Appearance: White solid_x000D_ Applications: simple monosaccharide that can be used as an energy source as well as a component of glycolipids and glycoproteins._x000D_ Storage: Room Temperature_x000D_ Keywords: D-(+)-Galactose, D-galactose_x000D_ Grade: Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Boehm R, Donovan J, Sheth D, Durfor A, Roberts J, Isayeva I. In Vitro Sugar_x000D_ Interference Testing With Amperometric Glucose Oxidase Sensors. J Diabetes Sci_x000D_ Technol. 2019 Jan;13(1):82-95._x000D_ _x000D_ 2: Ng WY, Tiong CC, Jacob E. Maltose interference-free test strips for blood_x000D_ glucose testing at point-of-care: a laboratory performance evaluation. Diabetes_x000D_ Technol Ther. 2010 Nov;12(11):889-93._x000D_ _x000D_ 3: Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F,_x000D_ Mosca A. Comparative performance assessment of point-of-care testing devices for_x000D_ measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol._x000D_ 2015 Mar;9(2):268-77._x000D_ _x000D_ 4: Schleis TG. Interference of maltose, icodextrin, galactose, or xylose with_x000D_ some blood glucose monitoring systems. Pharmacotherapy. 2007 Sep;27(9):1313-21._x000D_ _x000D_ 5: Paigen K, Pacholec F, Levy HL. A new method of screening for inherited_x000D_ disorders of galactose metabolism. J Lab Clin Med. 1982 Jun;99(6):895-907._x000D_ _x000D_ 6: Ba Y, Xu J, Yuan L, Zhu H, Yang Y, Lam MM, Zhang S, Xiao M, Xu J, Zhang R,_x000D_ Chen C. Assessment of the performance of blood glucose monitoring systems for_x000D_ monitoring dysglycaemia in neonatal patients. BMJ Paediatr Open. 2018 Oct_x000D_ 23;2(1):e000339._x000D_ _x000D_ 7: Sicard C, Shek N, White D, Bowers RJ, Brown RS, Brennan JD. A rapid and_x000D_ sensitive fluorimetric β-galactosidase assay for coliform detection using_x000D_ chlorophenol red-β-D-galactopyranoside. Anal Bioanal Chem. 2014_x000D_ Sep;406(22):5395-403._x000D_ _x000D_ 8: McDougall GJ, Fry SC. Structure-activity relationships for xyloglucan_x000D_ oligosaccharides with antiauxin activity. Plant Physiol. 1989 Mar;89(3):883-7._x000D_ 9: Lee YK, Puong KY. Competition for adhesion between probiotics and human_x000D_ gastrointestinal pathogens in the presence of carbohydrate. Br J Nutr. 2002_x000D_ Sep;88 Suppl 1:S101-8. _x000D_ _x000D_ Products Related to Galactose for Interference Testing : Interference

• Short Description:

  Catalog Number: C2010416 (500 mg)_x000D_ Galactose for Interference Testing is a simple monosaccharide that can be used as an energy source as well as a component of glycolipids and glycoproteins. This product can used to test galactose interference in immunoassays. For in vitro research use only. Not for human or animal use. Custom bulk orders of this product are available upon request._x000D_ _x000D_

• Weight:

  0.8

• Length:

  2

• Width:

  0.9

• Height :

  0.9